• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年声门型 T1 期喉癌放疗的预后因素

Prognostic factors in elderly patients with T1 glottic cancer treated with radiotherapy.

机构信息

Department of Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Cracow Branch, Garncarska 11, 31-115, Cracow, Poland.

Department of Radiotherapy for Children and Adults, University Children's Hospital of Cracow, Wielicka 265, 30-663, Cracow, Poland.

出版信息

Sci Rep. 2021 Sep 6;11(1):17717. doi: 10.1038/s41598-021-96146-5.

DOI:10.1038/s41598-021-96146-5
PMID:34489495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8421427/
Abstract

The aim of the study was the evaluation of the effectiveness of radiotherapy in elderly T1 glottic cancer patients and prognostic factors with particular focus on comorbidities. Five-year overall survival, disease-specific survival, and local control rates were 63%, 92%, and 93%, respectively. Multivariate analysis showed that the following factors had statistically significant impact on local relapse risk and cancer death risk: diabetes, underweight, and fraction dose of 2 Gy. High number of comorbidities, high CCI, and underweight negatively influenced overall survival. A retrospective analysis was performed in a group of 131 T1N0M0 glottic cancer patients aged 70 and above treated with irradiation at the National Institute of Oncology in Cracow between 1977 and 2007. In the analyzed group men prevailed (92%) of mean age of 74 years. Each patient was diagnosed with at least one comorbidity with the following comorbid conditions being most frequent: hypertension, ischemic heart disease, and chronic obstructive pulmonary disease. In the studied group, the effect of comorbidities on overall survival was evaluated using Charlson Comorbidity Index (CCI). Twenty five (19%) patients showed underweight. All patients were irradiated once daily, 5 days a week, to a total dose of 60-70 Gy with a fraction dose of 2 or 2.5 Gy. Radiotherapy is an effective treatment modality in elderly T1 glottic cancer patients. Diabetes as comorbidity, underweight, and conventional dose fractionation decrease the probability of curative effect of radiotherapy in this group of patients, while high number of comorbidities diminishes the probability of long-term survival.

摘要

本研究的目的是评估放疗在老年 T1 声门型癌症患者中的疗效和预后因素,尤其关注合并症。5 年总生存率、疾病特异性生存率和局部控制率分别为 63%、92%和 93%。多因素分析表明,以下因素对局部复发风险和癌症死亡风险有统计学显著影响:糖尿病、体重不足和 2Gy 分次剂量。合并症数量多、CCI 高和体重不足对总生存率有负面影响。对 1977 年至 2007 年在克拉科夫国家肿瘤研究所接受放疗的 131 名 70 岁及以上 T1N0M0 声门型癌症患者进行回顾性分析。在分析组中,男性(92%)占优势,平均年龄为 74 岁。每位患者至少诊断有一种合并症,最常见的合并症有:高血压、缺血性心脏病和慢性阻塞性肺疾病。在研究组中,使用 Charlson 合并症指数(CCI)评估合并症对总生存率的影响。25 例(19%)患者表现为体重不足。所有患者均每天接受一次放疗,每周 5 天,总剂量为 60-70Gy,分次剂量为 2 或 2.5Gy。放射治疗是老年 T1 声门型癌症患者的有效治疗方法。糖尿病作为合并症、体重不足和常规剂量分割降低了该组患者放疗疗效的可能性,而合并症数量多则降低了长期生存的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb8/8421427/14cc6fbf3101/41598_2021_96146_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb8/8421427/08a0ad8a6bda/41598_2021_96146_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb8/8421427/be00f86058ca/41598_2021_96146_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb8/8421427/7cac41432b72/41598_2021_96146_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb8/8421427/d993a52f71b3/41598_2021_96146_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb8/8421427/ce346ee8c5d5/41598_2021_96146_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb8/8421427/836003f9ba7e/41598_2021_96146_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb8/8421427/81b545f1f872/41598_2021_96146_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb8/8421427/14cc6fbf3101/41598_2021_96146_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb8/8421427/08a0ad8a6bda/41598_2021_96146_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb8/8421427/be00f86058ca/41598_2021_96146_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb8/8421427/7cac41432b72/41598_2021_96146_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb8/8421427/d993a52f71b3/41598_2021_96146_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb8/8421427/ce346ee8c5d5/41598_2021_96146_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb8/8421427/836003f9ba7e/41598_2021_96146_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb8/8421427/81b545f1f872/41598_2021_96146_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb8/8421427/14cc6fbf3101/41598_2021_96146_Fig8_HTML.jpg

相似文献

1
Prognostic factors in elderly patients with T1 glottic cancer treated with radiotherapy.老年声门型 T1 期喉癌放疗的预后因素
Sci Rep. 2021 Sep 6;11(1):17717. doi: 10.1038/s41598-021-96146-5.
2
Prognostic factors in patients with T1 glottic cancer treated with radiotherapy.声门型 T1 喉癌放疗患者的预后因素。
Strahlenther Onkol. 2019 Sep;195(9):792-804. doi: 10.1007/s00066-019-01481-2. Epub 2019 Jun 18.
3
Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control.T1、2期声门癌的放射治疗:总治疗时间对局部控制的影响。
Radiother Oncol. 1996 Sep;40(3):225-32. doi: 10.1016/0167-8140(96)01796-3.
4
Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.分次剂量、总剂量及总治疗时间对T1-T2期声门癌局部控制的影响。
Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):115-26. doi: 10.1016/s0360-3016(97)00284-8.
5
Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.T1a和T1bN0M0期声门癌放疗的长期结果
Laryngoscope. 2008 Aug;118(8):1417-21. doi: 10.1097/MLG.0b013e3181781791.
6
Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.放射分次剂量对早期声门癌局部控制率的影响。体内肿瘤生长及放射反应参数的模型分析。
Arch Otolaryngol Head Neck Surg. 1994 Jul;120(7):737-42. doi: 10.1001/archotol.1994.01880310041008.
7
Hypofractionation vs. conventional radiotherapy fractionation in the conservative treatment of T1 glottic cancer: a prospective cohort study.T1 声门型喉癌保喉治疗中适形放疗与常规放疗分割方式的比较:一项前瞻性队列研究。
Clin Transl Oncol. 2020 Jan;22(1):151-157. doi: 10.1007/s12094-019-02118-7. Epub 2019 Jun 1.
8
Outcomes of radiation therapy for T1 glottic carcinoma from an Italian regional series with doses ranging from 60 to 66 Gy.来自意大利地区系列的T1声门癌放射治疗结果,剂量范围为60至66 Gy。
Tumori. 2010 Jul-Aug;96(4):577-81. doi: 10.1177/030089161009600410.
9
Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.T1期声门癌患者治疗前血红蛋白水平的意义
Radiat Oncol Investig. 1999;7(1):42-8. doi: 10.1002/(SICI)1520-6823(1999)7:1<42::AID-ROI6>3.0.CO;2-W.
10
Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.T1、2期声门癌的超分割加速放疗。时间剂量因素的考量。
Strahlenther Onkol. 2008 Jul;184(7):364-9. doi: 10.1007/s00066-008-1819-1. Epub 2008 Oct 1.

引用本文的文献

1
Awake Flexible Bronchoscopy Intubation Practice Among Otorhinolaryngology Surgery: An Observation Study Based on Practice Video Recordings and Clinical Data.耳鼻喉科手术中清醒状态下可弯曲支气管镜插管实践:一项基于实践视频记录和临床数据的观察性研究
Clin Interv Aging. 2025 Aug 22;20:1325-1336. doi: 10.2147/CIA.S530162. eCollection 2025.
2
Comparison of prognostic and treatment between T1a and T1b glottic cancer: a propensity score-matched SEER database analysis.T1a 和 T1b 声门型喉癌患者预后和治疗比较:基于倾向评分匹配 SEER 数据库分析。
Eur Arch Otorhinolaryngol. 2023 Jul;280(7):3313-3322. doi: 10.1007/s00405-023-07953-7. Epub 2023 Apr 11.
3

本文引用的文献

1
Prognostic factors in patients with T1 glottic cancer treated with radiotherapy.声门型 T1 喉癌放疗患者的预后因素。
Strahlenther Onkol. 2019 Sep;195(9):792-804. doi: 10.1007/s00066-019-01481-2. Epub 2019 Jun 18.
2
Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer.对于 T1/T2 声门型喉癌,使用适形放疗降低剂量可减少毒性,同时保持肿瘤学结果。
Sci Rep. 2017 Nov 16;7(1):15732. doi: 10.1038/s41598-017-15974-6.
3
Radiotherapy for laryngeal cancer-technical aspects and alternate fractionation.
Causes of death after laryngeal cancer diagnosis: A US population-based study.
喉癌诊断后的死因:一项基于美国人群的研究。
Eur Arch Otorhinolaryngol. 2023 Apr;280(4):1855-1864. doi: 10.1007/s00405-022-07730-y. Epub 2022 Nov 10.
喉癌的放射治疗——技术层面与交替分割放疗
J Radiat Res. 2017 Jul 1;58(4):495-508. doi: 10.1093/jrr/rrx023.
4
Patterns of Care for Patients With Early-Stage Glottic Cancer Undergoing Definitive Radiation Therapy: A National Cancer Database Analysis.接受根治性放射治疗的早期声门癌患者的护理模式:一项国家癌症数据库分析
Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1014-1021. doi: 10.1016/j.ijrobp.2017.03.050. Epub 2017 Apr 6.
5
A large French multicenter retrospective series of T1-T2N0 vocal cords carcinomas treated with exclusive irradiation.一项关于采用单纯放疗治疗T1-T2N0期声带癌的大型法国多中心回顾性研究系列。
Cancer Radiother. 2017 Jun;21(4):286-290. doi: 10.1016/j.canrad.2017.01.015. Epub 2017 May 15.
6
Hypofractionated Radiotherapy for Patients with Early-Stage Glottic Cancer: Patterns of Care and Survival.早期声门型喉癌患者的分割放疗:治疗模式与生存情况。
J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx042.
7
Body mass index and prognosis in patients with head and neck cancer.体重指数与头颈癌患者的预后
Head Neck. 2017 Jun;39(6):1226-1233. doi: 10.1002/hed.24760. Epub 2017 Mar 21.
8
Comparison of survival between radiation therapy and trans-oral laser microsurgery for early glottic cancer patients; a retrospective cohort study.早期声门癌患者放射治疗与经口激光显微手术生存率的比较;一项回顾性队列研究。
J Otolaryngol Head Neck Surg. 2016 Aug 2;45(1):42. doi: 10.1186/s40463-016-0155-1.
9
Prognostic value of body mass index before treatment for laryngeal squamous cell carcinoma.喉鳞状细胞癌治疗前体重指数的预后价值
Cancer Biol Med. 2015 Dec;12(4):394-400. doi: 10.7497/j.issn.2095-3941.2015.0043.
10
Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions.早期声门癌的根治性大分割放疗:20次分割给予55Gy的经验
Radiat Oncol. 2015 Sep 23;10:203. doi: 10.1186/s13014-015-0505-6.